| Literature DB >> 33167439 |
Elena Chugunova1,2, Almir Gazizov1,2, Marina Sazykina3, Nurgali Akylbekov4, Anastasiya Gildebrant3, Ivan Sazykin3, Alexander Burilov1,2, Nurbol Appazov4,5, Shorena Karchava3, Maria Klimova3, Alexandra Voloshina1, Anastasia Sapunova1, Syumbelya Gumerova1, Ayrat Khamatgalimov1, Tatiana Gerasimova1, Alexey Dobrynin1, Olga Gogoleva2, Vladimir Gorshkov2.
Abstract
A series of novelEntities:
Keywords: anti-cancer activity; apoptosis; bacterial biofilm; benzofuroxan; fungistatic activity; quantum chemical calculations
Year: 2020 PMID: 33167439 PMCID: PMC7663979 DOI: 10.3390/ijms21218292
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Scheme 1Reaction of 4,6-dichloro-5-nitrobenzofuroxan 1 with aromatic amines.
Scheme 2Reaction of 4,6-dichloro-5-nitrobenzofuroxan 1 with aliphatic amines.
Figure 1Molecular structure of compound 3a.
Figure 2Molecular structure of compound 3b.
Figure 3Molecular structure of compound 3c.
Figure 4Molecular structure of compound 3d.
Scheme 3Two possible ways for reaction of 4,6-dichloro-5-nitrobenzofuroxan 1 with aniline (A).
Relative energies (ΔE, kcal/mol), enthalpies (ΔH, kcal/mol) and Gibbs energies (ΔG, kcal/mol) of products Pa and Pb with HCl compared to initial reagents 4,6-dichloro-5-nitrobenzofuroxan 1 with aniline A (Scheme 3).
| Reaction Products | ΔE | ΔH | ΔG |
|---|---|---|---|
|
| 9.91 | 11.13 | 8.21 |
|
| 2.32 | 3.70 | 1.37 |
Relative energies (ΔE, kcal/mol), enthalpies (ΔH, kcal/mol), Gibbs free energies (ΔG, kcal/mol) and Highest occupied molecular orbital–lowest unoccupied molecular orbital (HOMO-LUMO) gaps (eV) for products Pa and Pb, reagents, pre-reaction complexes and transition states of the reaction of 4,6-dichloro-5-nitrobenzofuroxan 1 with aniline A.
| ΔE | ΔH | ΔG | HOMO-LUMO | |
|---|---|---|---|---|
|
| 0.00 | 0.00 | 0.00 | – |
|
| −3.41 | −2.09 | 5.69 | – |
|
| −3.20 | −1.90 | 6.46 | – |
|
| 15.02 | 16.28 | 30.80 | 3.10 |
|
| 29.61 | 30.75 | 44.41 | 2.13 |
|
| −9.91 | −11.13 | −8.21 | 2.99 |
|
| −2.32 | −3.70 | −1.37 | 2.86 |
Biofilm formation (%) by V. aquamarinus DSM 26054 in the presence of benzofuroxan derivatives in reference to control (control = 100%).
| Compound | Biofilm Formation, % | |||||
|---|---|---|---|---|---|---|
| Compound Concentration, M | ||||||
| 1 × 10−9 | 1 × 10−8 | 1 × 10−7 | 1 × 10−6 | 1 × 10−5 | 1 × 10−4 | |
|
| 104.09 | 81.39 | 51.29 * | 104.19 * | 116.74 | 108.56 * |
|
| 29.56 * | 18.75 * | 49.17 * | 98.92 | 46.33 * | 5.78 * |
|
| 83.88 | 22.91 * | 67.33 * | 91.23 | 121.82 * | 6.23 * |
|
| 15.18 * | 11.69 * | 57.03 * | 100.31 | 63.01 * | 118.72 * |
|
| 85.02 | 85.82 | 41.01 * | 96.34 | 65.93 * | 94.48 * |
|
| 66.58 | 9.31 * | 11.34 * | 43.56 * | 96.57 | 98.97 |
|
| 88.50 | 25.54 * | 37.51 * | 88.43 * | 92.32 | 100.88 |
|
| 26.21 * | 21.15 * | 70.11 * | 96.38 | 116.36 | 110.85 * |
|
| 25.67 * | 26.88 * | 63.58 * | 96.08 | 96.24 | 103.47 |
|
| 45.78 * | 22.40 * | 27.37 * | 79.81 * | 108.84 | 107.18 |
|
| 103.42 | 102.43 | 99.39 | 103.80 | 81.50 * | 103.42 |
* Differences compared to the control samples are statistically significant, t criterion, p < 0.05; the solutions of appropriate solvent in ethanol with the same concentration were used as control in experiments with benzofuroxans; six replicates were done for each treatment and control; ** Data for compound 3f were first published in [40].
Figure 5Fungistatic activity of the tested compounds determined on two isolates of Microdochium nivale: (A) isolate 1; (B) isolate 21. The presented values are averages ± standard error of at least three biological replicates. Red columns—4 day of incubation, yellow columns—5 day of incubation, hatched columns—6 day of incubation.
Figure 6Structure of the tautomers of compound 6.
In vitro cytotoxic effects (IC50 μM) and selectivity index values (SI) of Test compound a.
| Test Compound | Cancer Cell Lines | Normal Cell Lines | |||||||
|---|---|---|---|---|---|---|---|---|---|
| M-HeLa | MCF7 | PANC-1 | T98G | Chang Liver | |||||
| IC50 | SI | IC50 | SI | IC50 | SI | IC50 | SI | ||
|
| 45.9 ± 3.7 | 2.0 | >100 | n.s. | >100 | n.s | 28.3 ± 2.3 | 3.3 | 93.8 ± 8.3 |
|
| 60.6 ± 4.7 | 1.0 | 69.2 ± 5.7 | n.s. | 82.7 ± 7.3 | n.s | 12.7 ± 1.1 | 5.0 | 62.7 ± 5.5 |
|
| 4.8 ± 0.4 | 12.8 | 3.7 ± 0.2 | 16.6 | 59.2 ± 4.6 | 1.0 | 20.4 ± 1.7 | 3 | 61.3 ± 5.1 |
|
| 16.6 ± 1.4 | >6 | 67.9 ± 5.7 | >1.5 | 61.3 ± 5.1 | >1.6 | 14.7 ± 1.2 | >6.8 | >100 |
|
| 62.7 ± 5.4 | 1.0 | 79.5 ± 6.4 | n.s. | 50.0 ± 4.1 | 1.3 | 21.5 ± 1.8 | 3.0 | 62.7 ± 5.6 |
|
| 16.0 ± 1.3 | 4.0 | 8.1 ± 0.7 | 8.0 | >100 | n.s. | 59.8 ± 4.8 | 1.1 | 64.4 ± 5.7 |
|
| 56.5 ± 4.5 | 1.8 | >100 | n.s. | >100 | n.s. | 22.7 ± 1.9 | 4.4 | 100 |
|
| 60.8 ± 4.8 | >1.6 | >100 | n.s. | 50.0 ± 3.9 | >2 | 65.0 ± 5.8 | >1.5 | >100 |
|
| 49.3 ± 3.9 | >2 | >100 | n.s. | 38 ± 2.9 | >2.6 | >100 | n.s. | >100 |
|
| 61.0 ± 5.2 | 1.1 | 79.1 ± 6.2 | n.s. | >100 | n.s. | 31.6 ± 2.5 | 2.1 | 67.1 ± 5.7 |
|
| 61.6 ± 5.2 | 1.1 | >100 | n.s. | >100 | n.s. | 57.1 ± 4.3 | 1.1 | 65.2 ± 5.8 |
|
| 62.2 ± 5.6 | >1.6 | >100 | n.s. | >100 | n.s. | >100 | n.s. | >100 |
|
| >100 | n.s. | >100 | n.s. | >100 | n.s. | >100 | n.s. | >100 |
|
| 3.0 ± 0.1 | 1.0 | 3.0 ± 0.2 | 1.0 | 3.3 ± 0.1 | 1.0 | 6.8 ± 0.5 | n.s. | 3.0 ± 0.2 |
|
| 28 ± 2.5 | 1.5 | 25 ± 2.2 | 1.7 | – | 42.1 ± 3.5 | |||
a The experiments were repeated for three times. The results are expressed as the mean ± standard deviation (SD); n.s.—no selectivity.
Figure 7Apoptotic effects of compounds 3c and 3f on M-HeLa cells. (A) M-HeLa cells were treated with the indicated compounds at indicated concentrations for 24 h. Apoptotic effects were measured by flow cytometry using annexin V- Alexa Fluor 647 staining protocol. The values are presented as the mean ± SD (n = 3). L—living cells; D—dead cells; Ea—early apoptotic cells; La—late apoptotic cells. (B) Representative histograms for the numbers of cells (% of total) in the early and late stages of apoptosis for the control and experimental groups. The values are presented as the mean ± SD (n = 3): (*) p < 0.01 compared to control.
Figure 8Flow cytometry analysis of M-Hela cells treated with compounds 3c and 3f along with the quantification of % of cells with red aggregates. The values are presented as mean ± SD.
Figure 9Effect of 3c and 3f on cell cycle progression of M-HeLa by flow cytometry.